コンテンツへスキップ
Merck

K-002

Supelco

ケタミン 塩酸塩 溶液

1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

ログイン組織・契約価格を表示する


About This Item

実験式(ヒル表記法):
C13H17Cl2NO
CAS番号:
分子量:
274.19
EC Number:
UNSPSCコード:
41116107
NACRES:
NA.24

グレード

certified reference material

品質水準

形状

liquid

特徴

Snap-N-Spike®/Snap-N-Shoot®

包装

ampule of 1 mL

メーカー/製品名

Cerilliant®

drug control

psicótropo (Spain)

濃度

1.0 mg/mL in methanol (as free base)

テクニック

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

アプリケーション

forensics and toxicology

フォーマット

single component solution

保管温度

−20°C

InChI

1S/C13H16ClNO.ClH/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14;/h2-3,6-7,15H,4-5,8-9H2,1H3;1H

InChI Key

VCMGMSHEPQENPE-UHFFFAOYSA-N

詳細

This certified solution standard is suitable for use as starting material in calibrators or controls for a variety of LC/MS or GC/MS testing applications from forensic analysis and clinical toxicology to urine drug testing.

Ketamine is a phencyclidine type of anaesthetic drug that blocks the N-methyl-d-aspartate (NMDA) receptors present on neurons. It is also an abused drug owing to its euphoric and hallucinogenic effects. The drug is also abused at clubs, raves, or parties for its noted hallucinogenic and dissociative properties and is prescribed by some doctors as an off-label treatment for depression.

アプリケーション

The certified reference solution (CRM) in solution can also be used as follows:
  • Development of a chiral liquid chromatography-tandem mass spectrometric (LC-MS/MS) method to quantify enantiomers of ketamine and norketamine in plasma, brain, and cerebrospinal fluid samples obtained from mouse
  • Multi-residue and non-destructive analysis of ketamine, methamphetamine, heroin, and cocaine by a near-infrared spectroscopic (NIR) method in seized drug samples
  • Combined detection and estimation of ketamine, free methamphetamine, pethidine, and tramadol in human urine samples using dispersive liquid-liquid microextraction (DLLME) and gas chromatography-mass spectrometry (GC-MS)
  • Electrochemical determination of ketamine in human urine samples using a metal-organic framework/graphene nanocomposite (MOFs@G) modified screen-printed electrode (SPE) after the UV polymerization of molecularly imprinted membranes on its surface
  • Simultaneous analysis of ketamine, GHB, norketamine, phenobarbital, thiopental, zolpidem, zopiclone, and phenytoin in human urine samples by a LC-MS/MS procedure following a four-step liquid-liquid extraction of the samples

特徴および利点

  • Fully characterized under ISO/IEC 17025 and ISO 17034 accreditation
  • Accompanied with a comprehensive Certificate of Analysis (CoA) with data on stability, homogeneity, accuracy of concentration, uncertainty, and traceability
  • Rigorously tested through real-time stability studies to ensure accuracy and shelf life
  • Gravimetrically prepared using qualified precision balances to ensure minimal uncertainty
  • Flame sealed under argon into ampoules for long-term shelf life
  • Offered in a convenient, DEA-exempt format to improve laboratory efficiency

法的情報

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

ピクトグラム

FlameSkull and crossbonesHealth hazard

シグナルワード

Danger

危険有害性情報

危険有害性の分類

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

ターゲットの組織

Eyes

保管分類コード

3 - Flammable liquids

WGK

WGK 2

引火点(°F)

49.5 °F - closed cup

引火点(℃)

9.7 °C - closed cup


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

消防法

第4類:引火性液体
アルコール類
危険等級II

労働安全衛生法名称等を表示すべき危険物及び有害物

名称等を表示すべき危険物及び有害物

労働安全衛生法名称等を通知すべき危険物及び有害物

名称等を通知すべき危険物及び有害物

Jan Code

K-002-CC:
K-002-1ML:


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Ege T Kavalali et al.
The American journal of psychiatry, 169(11), 1150-1156 (2013-03-28)
Recent clinical studies have demonstrated that a single subpsychotomimetic dose of ketamine, an ionotropic glutamatergic N-methyl-D-aspartate (NMDA) receptor antagonist, produces a rapid antidepressant response in patients with major depressive disorder, with effects lasting up to 2 weeks. Despite enthusiasm about
Going beyond anesthesia in space exploration missions: emergency medicine and emergency medical care.
Jochen Hinkelbein et al.
Aviation, space, and environmental medicine, 84(7), 747-747 (2013-07-17)
Ketamine infusion as a treatment for major depressive disorder: a new role for anesthesiologists?
Joshua D Dilley et al.
Middle East journal of anaesthesiology, 21(6), 871-873 (2013-05-03)
Ketamine-medetomidine regimen for chemical immobilisation of free-ranging chimpanzees (Pan troglodytes schweinfurthii) in Uganda.
D Hyeroba et al.
The Veterinary record, 172(18), 475-475 (2013-04-02)
Kaixin Fu et al.
Biosensors & bioelectronics, 143, 111636-111636 (2019-09-03)
Ketamine is one of the most widely abused drugs in the world and poses a serious threat to human health and social stability; therefore, the ability to accurately monitor the substance in real-time is necessary. However, several problems still exists

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)